Sun BioPharma Inc

-0.23 (-6.57%)
Earnings Announcements

Sun BioPharma Reports Q3 2020 Financial Results

Published: 11/12/2020 21:54 GMT
(SNBP) - Sun Biopharma, Inc. Provides Business Update and Reports Q3 2020 Financial Results.
Q3 Loss per Share $0.21.
Upcoming Milestones Include Completing Sbp-101's Enrollment in Current Phase 1b Trial in Q4.
Sun Biopharma - Believe Sbp-101 Has Potential to Expand Into Other Cancers With Known Elevated Levels of Polyamine Metabolism.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.15

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.15

More details on our Analysts Page.